Breast cancer in dad's family may be missed

Key points
- Women may often lack information about breast cancer on their father's side of the family, a problem that could cloud their view of their own risk, new research suggests.
- In a study of 899 women age 40 and older, the researchers found that 16 percent of the women said there was a history of breast cancer in their mother's family, while just 10 percent reported a paternal history of the disease.
- The discrepancy is suspect because statistically speaking, women should generally have a similar number of maternal and paternal relatives affected by breast cancer.
- Quillin of Virginia Commonwealth University in Richmond and colleagues, have implications for both women and their doctors, who use family history to help gauge whether a woman has a higher-than-average breast cancer risk.
Women may often lack information about breast cancer on their father's side of the family, a problem that could cloud their view of their own risk, new research suggests.
In a study of 899 women age 40 and older, the researchers found that 16 percent of the women said there was a history of breast cancer in their mother's family, while just 10 percent reported a paternal history of the disease.
The discrepancy is suspect because statistically speaking, women should generally have a similar number of maternal and paternal relatives affected by breast cancer.
The findings, according to Dr. John M. Quillin of Virginia Commonwealth University in Richmond and colleagues, have implications for both women and their doctors, who use family history to help gauge whether a woman has a higher-than-average breast cancer risk.
The researchers report their findings in the American Journal of Preventive Medicine.
Women need to find out all they can about breast cancer in their father's family, and doctors need to specifically question them about it, Dr. Quillin told Reuters Health.
Family history is one of the established risk factors for breast cancer, and most studies have indicated that this genetic risk is equally likely to be passed on from mothers or fathers, Quillin said.
It is possible, he noted, that women in his study accurately reported their family history of breast cancer. The women all volunteered for the study, Quillin explained, and if a large number of women with a maternal family history of breast cancer enrolled, that could explain the discrepancy in the findings.
It's more likely, however, that the women were less aware of breast cancer on the father's side of the family, according to the researchers.
But greater awareness isn't only a matter of women delving more deeply into their father's family history. Quillin said men need to learn about their relatives' health history, then share that information with their own family.
"Maternal and paternal family histories each only tell half of the genetic story," he noted.
SOURCE: American Journal of Preventive Medicine, September 2006.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew breast cancer drug may be effective against other types of cancer
Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature…
30 December 2015
NewsNYU nursing study examines obesity in relation to breast cancer related lymphedema
Each year, about 1.38 million women worldwide are diagnosed with breast cancer. Advances in treatment have facilitated a 90% five-year survival rate among those treated. Given the increased rate and length of survival…
18 December 2015
NewsNeoadjuvant use of pertuzumab in HER2-positive breast cancer
Pertuzumab (trade name: Perjeta) is approved for two therapeutic indications. Its use in combination with trastuzumab and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable…
4 December 2015



